GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » COGS-to-Revenue

Fresenius Medical Care AG (Fresenius Medical Care AG) COGS-to-Revenue : 0.73 (As of Dec. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Fresenius Medical Care AG COGS-to-Revenue?

Fresenius Medical Care AG's Cost of Goods Sold for the three months ended in Dec. 2023 was $3,968 Mil. Its Revenue for the three months ended in Dec. 2023 was $5,439 Mil.

Fresenius Medical Care AG's COGS to Revenue for the three months ended in Dec. 2023 was 0.73.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Fresenius Medical Care AG's Gross Margin % for the three months ended in Dec. 2023 was 27.06%.

Fresenius Medical Care AG COGS-to-Revenue Historical Data

The historical data trend for Fresenius Medical Care AG's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius Medical Care AG COGS-to-Revenue Chart

Fresenius Medical Care AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.69 0.69 0.73 0.75 0.75

Fresenius Medical Care AG Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.75 0.76 0.75 0.75 0.73

Fresenius Medical Care AG COGS-to-Revenue Calculation

Fresenius Medical Care AG's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=15843.633 / 21214.413
=0.75

Fresenius Medical Care AG's COGS to Revenue for the quarter that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=3967.536 / 5439.352
=0.73

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius Medical Care AG  (NYSE:FMS) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Fresenius Medical Care AG's Gross Margin % for the three months ended in Dec. 2023 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 3967.536 / 5439.352
=27.06 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Fresenius Medical Care AG COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fresenius Medical Care AG's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius Medical Care AG (Fresenius Medical Care AG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius Medical Care AG (NYSE:FMS) » Definitions » COGS-to-Revenue
Comparable Companies
XTER:FRE XTER:RHK XTER:M12 XTER:MED XTER:V3V XTER:MAK FRA:EIF HCA SAU:4013 SZSE:300015 BKK:BDMS UHS DVA ADX:PUREHEALTH BSP:RDOR3 HKSE:06618 XKLS:5225 NSE:APOLLOHOSP THC CHE
Traded in Other Exchanges
FMCQF:USA FME:Italy FMEd:UK 0H9X:UK FME:Germany FMEA:Germany FME:Germany FME:Germany FMEA:Germany FME:Germany FMSC34:Brazil FME:Austria
Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Website
https://www.freseniusmedicalcare.com
Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of December 2022. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. Services account for roughly 80% of firmwide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.
Executives
Helen Pring Giza Board of Directors